Research2 sources
Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted
The Brief · written from 2 sources
- A Mayo Clinic study in JAMA Neurology found that blood levels of phosphorylated tau 217 (p-tau217) were linked with 5- and 10-year risks of mild cognitive impairment and dementia.
- The study cohort consisted of cognitively unimpaired individuals.
- The authors say the blood marker may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia up to 10 years ahead.
Why it matters
A blood test could eventually help identify people without symptoms who face higher future risk of cognitive decline, which matters for research on early detection of Alzheimer's disease.
Who’s affected
- researchers and clinicians working on dementia and Alzheimer's disease
- people concerned about their long-term cognitive risk
- #alzheimer's
- #dementia
- #blood biomarker
- #p-tau217
- #neurology
- #cognitive decline
(MedPage Today) -- In a cohort of cognitively unimpaired individuals, blood levels of phosphorylated tau 217 (p-tau217) were linked with 5- and 10-year risks of developing mild cognitive impairment and dementia. (JAMA Neurology) Waves of cerebrospinal...
Timeline
Full coverage · 2 sources
- 2h ago ↗
Medical Xpress - latest medical and health news stories
Alzheimer's blood marker may help estimate cognitive impairment risk up to 10 years ahead - 8h ago ↗
MedPageToday.com - medical news for physicians
Blood Test Predicts Dementia; Diabetes and Alzheimer's; Parkinson's Data Retracted